Dr. Guangming Zhong: Curing Chlamydia Through the Gut: Medicine’s Next Big Thing?

Dr. Guangming Zhong featured in KSAT 12 & KSAT.com for his research with chlamydia.
Read More →

Researchers develop new model to test pancreatic cancer drugs

Dr. Bruno Doiron was featured on Kens5 for his model to induce pancreatic cancer in mice.
Read More →

A Mental Health Crisis Among Graduate Students

Teresa Evans, Ph.D., and Lindsay Bira, Ph.D., of UT Health San Antonio found that graduate students are more than six times as likely to experience depression and anxiety as compared to the general population.
Read More →

Dr. Thomas Boyer awarded NIH grants to study uterine fibroids

Thomas G. Boyer, Ph.D., professor of molecular medicine at UT Health San Antonio, has received two related NIH R01 grants to study uterine leiomyomas, also called uterine fibroids.
Read More →

Morilak Lab Receives CPRIT Grant To Study Cognitive Impairment

Dr. David Morilak was awarded the CPRIT grant used to study mechanisms and new treatments for cognitive impairment.
Read More →

A Potential Vaccine for Chlamydia

Dr. Guangming Zhong and his team have found that the site of first chlamydia exposure can make all the difference when it comes to patient outcomes.
Read More →

EPA awards University of Texas Health Science Center at San Antonio for waste prevention

The University of Texas Health Science Center at San Antonio was awarded as the "Texas Partner of the Year" by the U.S. Environmental Protection Agency for sustainable materials management practices to prevent and reduce municipal and select industrial waste.
Read More →

Scientists win $6 million grant for breast cancer drug development

UT Health San Antonio received $3.2 million of those funds to conduct preclinical testing of a therapeutic antibody.
Read More →